Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
The small intestine extends from
|
the pyloric sphincter to the ileocecal valve
|
|
accessory organs of the digestive system that are closely associated with the small intestine
|
The liver, gallbladder, and pancreas
|
|
The small intestine is divided into the
|
duodenum, jejunum, and ileum
|
|
macroscopically visible, crescent-shaped folds of the mucosa and submucosa. It extends around one-half to two-thirds of the circumference of the lumen of the small intestine.
|
plicae circulares
|
|
The absorptive surface area of the small intestine is increased by
|
plicae circulares, villi, and microvilli.
|
|
Exocrine cells in the mucosa of the small intestine secrete
|
mucus, peptidase, sucrase, maltase, lactase, lipase, and enterokinase
|
|
Endocrine cells secrete
|
cholecystokinin and secretin
|
|
The most important factor for regulating secretions in the small intestine is the presence of
|
chyme
|
|
The large intestine extends from
|
the ileocecal junction, where the ileum enters the large intestine, and ends at the anus
|
|
The large intestine consists of
|
the colon, rectum, and anal canal
|
|
The mucosa of the large intestine has a large number of goblet cells but does not have any
|
villi
|
|
The longitudinal muscle is limited to three distinct bands, called
|
teniae coli
|
|
Contraction of the teniae coli exerts pressure on the wall and creates a series of pouches, called
|
haustra
|
|
pieces of fat-filled connective tissue, attached to the outer surface of the colon.
|
Epiploic appendages
|
|
Unlike the small intestine, the large intestine produces no
|
digestive enzymes
|
|
Functions of the large intestine include
|
the absorption of water and electrolytes and the elimination of feces.
|
|
The rectum extends from the
|
sigmoid colon to the anal canal
|
|
Where does the rectum end?
|
about 5 cm below the tip of the coccyx, at the beginning of the anal canal
|
|
The last 2 to 3 cm of the digestive tract is the
|
anal canal
|
|
The mucosa of the rectum is folded to form
|
longitudinal anal columns
|
|
Rectal Cancer bone metastases can occur in the
|
pelvis or other bones
|
|
Risk factors for colorectal cancer:
|
Ulcerative colitis
Familial or multiple polyposis Crohn's Disease Low fiber diet Hx of Colon or Rectal Ca Hx of Colon or Rectal Polyps Family hx of colorectal ca or female genital cancer |
|
Ulcerative colitis is sometimes called
|
panulcerative colitis
|
|
a disease occurring in some families that consists of multiple adenomatous polyps of the colon which have high malignant potential.
|
Familial or multiple polyposis
|
|
a benign chronic granulomatous inflammatory disease of any or all parts of the colon
|
Crohn's disease
|
|
Risk factors for anal cancer include:
|
Over 50 y/o
More frequent in women |
|
Inflammation of the colon
|
colitis
|
|
The early signs of colorectal cancer
|
- Unexplained persistent diarrhea or constipation.
- Blood in or on the stool (can be bright red or very dark). - Narrower stools than usual. - Unexplained iron deficiency anemia. - Intermittent abdominal pain |
|
The following symptoms can be signs of rectal cancer:
|
- Blood in the stool.
- Diarrhea. - A sense of bowel movement urgency. - Feeling of inadequate emptying of bowel. - Excessive straining to have a bowel movement without passing of stools. |
|
The exact cause of colorectal cancer is unknown, however at least eight different genes involved can be traced to
|
dietary fat, particularly animal fat
|
|
During fat metabolism, bacteria in the bowel form
|
carcinogens (cancer-causing agents) that can irritate the intestinal lining
|
|
is thought to be somewhat protective because it helps accelerate the rate at which fats pass through the bowel and/or dilutes the concentration of fats, reducing the exposure of the large intestine to carcinogens.
|
A high-fiber diet
|
|
account for 90 to 95 percent of all large bowel tumors
|
Adenocarcinomas
|
|
cancers usually grow into the space within the colon
|
On the right side of the colon near the cecum
|
|
Colon cancers can become large enough to cause bleeding, in these cases this is often one of the first signs
|
anemia from chronic blood loss
|
|
Most polyps and cancers appear on which side of the colon?
|
Left side
|
|
typically constricts the bowel channel, causing partial blockage
|
Left-sided colon cancer
|
|
Typical symptoms of colon cancer include:
|
constipation, change in bowel habits, and narrow, ribbon-shaped stool when a cancer is low in the rectum.
|
|
When colon cancers do spread, it is usually through invasion of
|
nearby lymph nodes
|
|
colorectal cancers tend to be slow growing, gradually enlarging and eventually
|
penetrating the bowel wall
|
|
The most common sites of distant metastasis are
|
the liver, lungs, and brain
|
|
Rectal cancer can spread to
|
adjacent organs in the pelvic region, such as the ovaries or the prostate
|
|
6 x 9 cm pouch covered with peritoneum
|
Cecum (proximal right colon)
|
|
A vermiform (wormlike) diverticulum located in the lower cecum
|
Appendix
|
|
20-25 cm long, located behind the peritoneum
|
Ascending colon
|
|
Lies under right lobe of liver
|
Hepatic flexure
|
|
Lies anterior in abdomen, attached to gastrocolic ligament
|
Splenic flexure
|
|
Near tail of pancreas and spleen
|
Splenic flexure
|
|
10-15 cm long, located behind the peritoneum
|
Descending colon
|
|
Loop extending distally from border of left posterior major psoas muscle
|
Sigmoid colon
|
|
Between 10 and 15 cm from anal verge
|
Rectosigmoid segment
|
|
12 cm long; upper third covered by peritoneum; no peritoneum on lower third which is also called the rectal ampulla. About 10 cm of the rectum lies below the lower edge of the peritoneum (below the peritoneal reflection), outside the peritoneal cavity
|
Rectum
|
|
Most distal 4-5 cm to anal verge
|
Anal canal
|
|
A blood test measuring the presence of an antigen in malignancies arising in endodermal (embryonic) or gastrointestinal tissue. Persistent elevated levels indicate residual or recurrent metastatic carcinoma
|
CEA
|
|
What is a normal CEA?
|
< 2.5 ng/ml
|
|
CEA level that suggests extensive disease
|
> 10 ng/ml
|
|
CEA levels that suggest metastatic disease
|
> 20 ng/ml
|
|
Monitors post-therapeutic gastrointestinal cancer for recurrence; nonspecific to colorectal cancer
|
CA 19-9
|
|
Detects colon cancer; changing level indicates progression or regression of tumor load
|
CA 195
|
|
Criteria for TNM Clinical Staging:
|
Physical examination and history; histologic type; imaging (barium enema, chest x-ray, and so forth), endoscopy, and studies to determine presence or absence of distant metastases
|
|
Criteria for TNM Pathological Staging:
|
Information from clinical staging; surgical exploration; pathologic examination of resected specimen, including depth of penetration into wall of bowel; evaluation of number and location of involved lymph nodes
|
|
Synonyms for in situ carcinoma
|
Stage 0, non-infiltrating, superficial, no invasion of lamina propria, limited to mucosa, non-invasive, no penetration of the basement membrane
|
|
For Stage II and III rectal cancer, the recommended therapy is
|
surgery, high-dose pelvic irradiation, and chemotherapy.
|
|
removing the entire rectum, most of the sigmoid colon, the mesocolon and its regional lymph nodes, removes the anal sphincter and leaves the patient with a permanent colostomy
|
abdominoperineal resection
|
|
resection preserves the anal sphincter and preserves bowel continuity by creating an anastomosis after the segment of bowel containing the tumor is removed.
|
Anterior/Posterior
|
|
If tumor is below 5 cm from the anal verge, AP probably stands for
|
Abdominoperineal
|
|
If tumor is above 5 cm, AP probably means
|
Anterior/Posterior
|
|
When is chemotherapy recommended in colorectal cancer?
|
Stage III (positive lymph nodes)
|
|
What is the recommended chemotherapy for colorectal cancer?
|
5-FU alone
5-FU and levamisole (Biological Response Modifier) 5-FU and leucovorin (under clinical evaluation)-ancillary drug 5-FU plus radiation therapy for rectal cancer Portal vein infusion of 5-FU for known or suspected liver metastases (under clinical evaluation—has shown improvement in palliation but not in survival) |